Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on September 16, 2026

Co-Parenting Through Cancer: How One Mom Found Stability with Structure, Support, and TalkingParents
Ignitus Recovery Announces Acquisition of AIM Health: Building on a 20-Year Legacy
Medicare open enrollment 2027: Higher drug costs and plan changes make shopping around important
NADP Foundation Issues Request for Proposals
Top Centrifugal Pump Manufacturer Advances Reliable Fluid Handling Solutions
Horse Peak Gelatin Launch 2026: Natural Vitality Formula For Men Read HorsePeak Gummies Supplement Facts & Ingredients Highlights
Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
Joint Replacement Devices Market Size to Hit $31.09 Billion by 2030 – MarketsandMarkets™
Finding Connection Through Sign Language: Braydon's Journey
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
NEXGEL Announces Date for Investor Update Call
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
NeuroSigma Expands Payment Options for the Monarch eTNS® System
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.